A multifunctional heptamethine near-infrared dye for cancer theranosis

Biomaterials

Volumn 34, Issue 9, 2013, Pages 2244-2251

  Luo, Shenglin ^a   Tan, Xu ^a   Qi, Qingrong ^b   Guo, Qinyuan ^a   Ran, Xinze ^a   Zhang, Lilong ^a   Zhang, Erlong ^a   Liang, Yufeng ^b   Weng, Lingling ^b   Zheng, Hu ^b   Cheng, Tianmin ^a   Su, Yongping ^a   Shi, Chunmeng ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

^b SICHUAN UNIVERSITY   (China)

Author keywords

Cancer targeting; Molecular imaging; Multifunctional materials; Near infrared dyes; Theranostic agent

Indexed keywords

ANTICANCER ACTIVITIES; BIOLOGICAL CHARACTERIZATION; BROAD SPECTRUM; CANCER THERAPEUTICS; CANCER-TARGETING; CHEMICAL SYNTHESIS; COMMON STRATEGY; CONTRAST AGENT; MULTI-FUNCTIONAL MATERIALS; MULTI-STEP; MULTICOMPONENTS; MULTIFUNCTIONAL AGENTS; NEAR-INFRARED DYES; NEAR-INFRARED FLUORESCENCE IMAGING; THERANOSTIC AGENTS; THERAPEUTIC AGENTS; TUMOR INHIBITION; TUMOR XENOGRAFTS;

INFRARED DEVICES; MOLECULAR IMAGING; TUMORS;

DISEASES;

ANTINEOPLASTIC AGENT; CYCLOPHOSPHAMIDE; HEPTAMETHINE; IR 808DB; THERANOSTIC AGENT; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER THERAPY; CONTROLLED STUDY; DRUG TARGETING; FLUORESCENCE IMAGING; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; XENOGRAFT;

ANIMALS; ANTINEOPLASTIC AGENTS; CARBOCYANINES; CELLS, CULTURED; CONTRAST MEDIA; DIAGNOSTIC IMAGING; FLUORESCENT DYES; HELA CELLS; HUMANS; INDOLES; MALE; MICE; MICE, INBRED C57BL; MICE, NUDE; NEOPLASMS; RATS; RATS, SPRAGUE-DAWLEY; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84872395842     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2012.11.057     Document Type: Article

References (39)

1. Siegel R., Naishadham D., Jemal A. Cancer statistics. CA Cancer J Clin 2012, 62:10-29.
2. Humphrey R.W., Brockway-Lunardi L.M., Bonk D.T., Dohoney K.M., Doroshow J.H., Meech S.J., et al. Opportunities and challenges in the development of experimental drug combinations for cancer. J Natl Cancer Inst 2011, 103:1222-1226.
3. Richards M.A. The size of the prize for earlier diagnosis of cancer in England. Brit J Cancer 2009, 101:S125-S129.
4. Ozdemir V., Williams-Jones B., Glatt S.J., Tsuang M.T., Lohr J.B., Reist C. Shifting emphasis from pharmacogenomics to theragnostics. Nat Biotechnol 2006, 24:942-947.
5. Kievit F.M., Zhang M.Q. Cancer nanotheranostics: improving imaging and therapy by targeted delivery across biological barriers. Adv Mater 2011, 23:H217-H247.
6. Pene F., Courtine E., Cariou A., Mira J.P. Toward theragnostics. Crit Care Med 2009, 37:S50-S58.
7. Bardhan R., Lal S., Joshi A., Halas N.J. Theranostic nanoshells: from probe design to imaging and treatment of cancer. Acc Chem Res 2011, 44:936-946.
8. Santra S., Kaittanis C., Santiesteban O.J., Perez J.M. Cell-specific, activatable, and theranostic prodrug for dual-targeted cancer imaging and therapy. J Am Chem Soc 2011, 133:16680-16688.
9. Kim J.I., Lee B.S., Chun C., Cho J.K., Kim S.Y., Song S.C. Long-term theranostic hydrogel system for solid tumors. Biomaterials 2012, 33:2251-2259.
10. Majumdar D., Peng X.H., Shin D.M. The medicinal chemistry of theragnostics, multimodality imaging and applications of nanotechnology in cancer. Curr Top Med Chem 2010, 10:1211-1226.
11. Kelkar S.S., Reineke T.M. Theranostics: combining imaging and therapy. Bioconjug Chem 2011, 22:1879-1903.
12. Zhang Z.J., Wang L.M., Wang J., Jiang X.M., Li X.H., Hu Z.J., et al. Mesoporous silica-coated gold nanorods as a light-mediated multifunctional theranostic platform for cancer treatment. Adv Mater 2012, 24:1418-1423.
13. Fang C., Zhang M.Q. Nanoparticle-based theragnostics: integrating diagnostic and therapeutic potentials in nanomedicine. J Control Release 2010, 146:2-5.
14. Karra N., Benita S. The ligand nanoparticle conjugation approach for targeted cancer therapy. Curr Drug Metab 2012, 13:22-41.
15. Mitsunaga M., Ogawa M., Kosaka N., Rosenblum L.T., Choyke P.L., Kobayashi H. Cancer cell-selective in vivo near infrared photoimmunotherapy targeting specific membrane molecules. Nat Med 2011, 17:1685-1692.
16. Wang C.H., Kang S.T., Lee Y.H., Luo Y.L., Huang Y.F., Yeh C.K. Aptamer-conjugated and drug-loaded acoustic droplets for ultrasound theranosis. Biomaterials 2012, 33:1939-1947.
17. Won Y.W., Yoon S.M., Lim K.S., Kim Y.H. Self-assembled nanoparticles with dual effects of passive tumor targeting and cancer-selective anticancer effects. Adv Funct Mater 2012, 22:1199-1208.
18. Rabanel J.M., Aoun V., Elkin I., Mokhtar M., Hildgen P. Drug-loaded nanocarriers: passive targeting and crossing of biological barriers. Curr Med Chem 2012, 19:3070-3102.
19. Dimitrov D.S., Feng Y., Prabakaran P. Antibody-guided nanoparticles. J Comput Theor Nanosci 2008, 5:751-759.
20. Nie S.M. Understanding and overcoming major barriers in cancer nanomedicine. Nanomedicine(Lond) 2010, 5:523-528.
21. Desai N. Challenges in development of nanoparticle-based therapeutics. Aaps J 2012, 14:282-295.
22. Shi C.M., Zhang C., Su Y.P., Cheng T.M. Cyanine dyes in optical imaging of tumours. Lancet Oncol 2010, 11:815-816.
23. Zhang C., Liu T., Su Y.P., Luo S.L., Zhu Y., Tan X., et al. A near-infrared fluorescent heptamethine indocyanine dye with preferential tumor accumulation for in vivo imaging. Biomaterials 2010, 31:6612-6617.
24. Yang X., Shi C., Tong R., Qian W., Zhau H.E., Wang R., et al. Near IR heptamethine cyanine dye-mediated cancer imaging. Clin Cancer Res 2010, 16:2833-2844.
25. Luo S.L., Zhang E.L., Su Y.P., Cheng T.M., Shi C.M. A review of NIR dyes in cancer targeting and imaging. Biomaterials 2011, 32:7127-7138.
26. Tan X., Luo S.L., Wang D.C., Su Y.P., Cheng T.M., Shi C.M. A NIR heptamethine dye with intrinsic cancer targeting, imaging and photosensitizing properties. Biomaterials 2012, 33:2230-2239.
27. Anderson W.M., Delinck D.L., Benninger L., Wood J.M., Smiley S.T., Chen L.B. Cytotoxic effect of thiacarbocyanine dyes on human colon carcinoma cells and inhibition of bovine heart mitochondrial NADH-ubiquinone reductase activity via a rotenone-type mechanism by two of the dyes. Biochem Pharmacol 1993, 45:691-696.
28. Krieg M., Bilitz J.M. Structurally modified trimethine thiacarbocyanine dyes. Effect of N-alkyl substituents on antineoplastic behavior. Biochem Pharmacol 1996, 51:1461-1467.
29. McKeage M.J., Berners-Price S.J., Galettis P., Bowen R.J., Brouwer W., Ding L., et al. Role of lipophilicity in determining cellular uptake and antitumour activity of gold phosphine complexes. Cancer Chemother Pharmacol 2000, 46:343-350.
30. Hollosy F., Lorand T., Orfi L., Eros D., Keri G., Idei M. Relationship between lipophilicity and antitumor activity of molecule library of Mannich ketones determined by high-performance liquid chromatography, clogP calculation and cytotoxicity test. J Chromatogr B 2002, 768:361-368.
31. Oh M., Tanaka T., Kobayashi M., Furukawa T., Mori T., Kudo T., et al. Radio-copper-labeled Cu-ATSM: an indicator of quiescent but clonogenic cells under mild hypoxia in a Lewis lung carcinoma model. Nucl Med Biol 2009, 36:419-426.
32. Chen X.Y., Peng X.J., Cui A.J., Wang B.S., Wang L., Zhang R. Photostabilities of novel heptamethine 3H-indolenine cyanine dyes with different N-substituents. J Photoch Photobio A 2006, 181:79-85.
33. Zhang Z.R., Achilefu S. Synthesis and evaluation of polyhydroxylated near-infrared carbocyanine molecular probes. Org Lett 2004, 6:2067-2070.
34. Khorsid F.A., Mushref S.S. In vitro anticancer agent I-Tissue culture study of human lung cancer cells A549 II-Tissue culture study of mice leukemia cells L1210. Intl J Cancer Res 2006, 2:330-344.
35. Singh A.K., Ramakrishna G., Ghosh H.N., Palit D.K. Photophysics and ultrafast relaxation dynamics of the excited states of dimethylaminobenzophenone. J Phys Chem A 2004, 108:2583-2597.
36. Youssif B.G.M., Okuda K., Kadonosono T., Salem O.I.A.R., Hayallah A.A.M., Hussein M.A., et al. Development of a hypoxia-selective near-infrared fluorescent probe for non-invasive tumor imaging. Chem Pharm Bull 2012, 60:402-407.
37. Sevick-Muraca E.M. Translation of near-infrared fluorescence imaging technologies: emerging clinical applications. Annu Rev Med 2012, 63:217-231.
38. Escobedo J.O., Rusin O., Lim S., Strongin R.M. NIR dyes for bioimaging applications. Curr Opin Chem Biol 2010, 14:64-70.
39. Hwang S.B., Lee H.Y., Kim H.Y., Lee E.S., Bae J.W. Life-threatening acute hyponatremia with generalized seizure induced by low-dose cyclophosphamide in a patient with breast cancer. J Breast Cancer 2011, 14:345-348.